Stage IV Small Intestinal Adenocarcinoma AJCC v8
4 clinical trials · Condition
◉ Watch Stage IV Small Intestinal Adenocarcinoma AJCC v8
| Record | Firm | Date |
|---|---|---|
| Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders (NCT04729322) | M.D. Anderson Cancer Center | 2021-02-22 |
| Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers (NCT04205968) | SWOG Cancer Research Network | 2020-06-01 |
| Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors (NCT03108131) | M.D. Anderson Cancer Center | 2017-04-07 |
| Bevacizumab, Capecitabine, and Oxaliplatin in Treating Advanced Small Intestinal or Ampulla of Vater Adenocarcinoma (NCT01208103) | M.D. Anderson Cancer Center | 2011-05-06 |
Track Stage IV Small Intestinal Adenocarcinoma AJCC v8 automatically
Every clearance here is in the API, with alerts when new ones post.